10% CONVERTIBLE PROMISSORY NOTE DUE OCTOBER 10, 2017Premier Biomedical Inc • October 14th, 2016 • Biological products, (no disgnostic substances) • New York
THIS 10% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Promissory Notes of Premier Biomedical Inc. (the “Company”), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 10% Convertible Notes due October 10, 2017 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
EXCHANGE AGREEMENTExchange Agreement • October 14th, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • New York
THIS EXCHANGE AGREEMENT (the “Agreement”) is dated October 10, 2016 (the “Effective Date”), by and between Premier Biomedical, Inc. (the “Company”) and Redwood Management, LLC (the “Holder”).
WARRANT PURCHASE AGREEMENTWarrant Purchase Agreement • October 14th, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances) • Utah
This WARRANT PURCHASE AGREEMENT (this “Agreement”), dated as of October 10, 2016, is entered into by and among Typenex Co-Investment, LLC, a Utah limited liability company (“Seller”), Redwood Management, LLC, a Florida limited liability company (“Buyer”), and Premier Biomedical, Inc., a Nevada corporation (“Company”), for the purchase by Buyer of certain rights in and to a certain Warrant (as defined) held by Seller.
